These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32851000)

  • 1. A New Cage-Like Particle Adjuvant Enhances Protection of Foot-and-Mouth Disease Vaccine.
    Bidart J; Kornuta C; Gammella M; Gnazzo V; Soria I; Langellotti C; Mongini C; Galarza R; Calvinho L; Lupi G; Quattrocchi V; Marcipar I; Zamorano P
    Front Vet Sci; 2020; 7():396. PubMed ID: 32851000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FMD empty capsids combined with the Immunostant Particle Adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus.
    Bidart J; Mignaqui A; Kornuta C; Lupi G; Gammella M; Soria I; Galarza R; Ferella A; Cardillo S; Langellotti C; Quattrocchi V; Durocher Y; Wigdorovitz A; Marcipar I; Zamorano P
    Virus Res; 2021 May; 297():198339. PubMed ID: 33596405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early protection against foot-and-mouth disease virus in cattle using an inactivated vaccine formulated with Montanide ESSAI IMS D 12802 VG PR adjuvant.
    Quattrocchi V; Pappalardo JS; Langellotti C; Smitsaart E; Fondevila N; Zamorano P
    Vaccine; 2014 Apr; 32(19):2167-72. PubMed ID: 24631088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant effect of Cliptox on the protective immune response induced by an inactivated vaccine against foot and mouth disease virus in mice.
    Batista A; Quattrocchi V; Olivera V; Langellotti C; Pappalardo JS; Di Giacomo S; Mongini C; Portuondo D; Zamorano P
    Vaccine; 2010 Aug; 28(38):6361-6. PubMed ID: 20637310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
    Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G
    Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-inoculation of baculovirus and FMDV vaccine in mice, elicits very early protection against foot and mouth disease virus without interfering with long lasting immunity.
    Quattrocchi V; Molinari P; Langellotti C; Gnazzo V; Taboga O; Zamorano P
    Vaccine; 2013 May; 31(24):2713-8. PubMed ID: 23588086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatible cationic solid lipid nanoparticles as adjuvants effectively improve humoral and T cell immune response of foot and mouth disease vaccines.
    Li S; Yang Y; Lin X; Li Z; Ma G; Su Z; Zhang S
    Vaccine; 2020 Mar; 38(11):2478-2486. PubMed ID: 32057580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
    Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
    Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle.
    Saravanan P; Sreenivasa BP; Selvan RP; Basagoudanavar SH; Hosamani M; Reddy ND; Nathanielsz J; Derozier C; Venkataramanan R
    Vaccine; 2015 Jan; 33(5):670-7. PubMed ID: 25528522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine CCL20 plasmid improves protective efficacy of the Montanide ISA™ 206 adjuvanted foot-and-mouth disease vaccine in mice model.
    Jayeshbhai C; Hajam IA; Verma AK; Bhanuprakash V; Kondabattula G; Kishore S
    Vaccine; 2018 Aug; 36(35):5318-5324. PubMed ID: 30054161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
    Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oil-in-ionic liquid nanoemulsion-based adjuvant simultaneously enhances the stability and immune responses of inactivated foot-and-mouth disease virus.
    Lin X; Yang Y; Li S; Li Z; Sheng Y; Su Z; Zhang S
    Int J Pharm; 2022 Sep; 625():122083. PubMed ID: 35934167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine Dendritic Cell Activation, T Cell Proliferation and Antibody Responses to Foot-And-Mouth Disease, Is Similar With Inactivated Virus and Virus Like Particles.
    Quattrocchi V; Bidart J; Mignaqui AC; Ruiz V; Ferella A; Langellotti C; Gammella M; Ferraris S; Carrillo J; Wigdorovitz A; Durocher Y; Cardillo SB; Charleston B; Zamorano PI
    Front Vet Sci; 2020; 7():594. PubMed ID: 33195496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C; Barrera J; Pisano M; Zsak L; Grubman MJ; Mayr GA; Moraes MP; Kamicker BJ; Brake DA; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2016 Jun; 34(27):3214-3220. PubMed ID: 26707216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibody response induced FMDV vaccines in sheep correlates with early transcriptomic responses in blood.
    Jouneau L; Lefebvre DJ; Costa F; Romey A; Blaise-Boisseau S; Relmy A; Jaszczyszyn Y; Dard-Dascot C; Déjean S; Versillé N; Guitton E; Hudelet P; Curet M; De Clercq K; Bakkali-Kassimi L; Zientara S; Klonjkowski B; Schwartz-Cornil I
    NPJ Vaccines; 2020; 5(1):1. PubMed ID: 31908850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle.
    Xiao Y; Chen HY; Wang Y; Yin B; Lv C; Mo X; Yan H; Xuan Y; Huang Y; Pang W; Li X; Yuan YA; Tian K
    BMC Biotechnol; 2016 Jul; 16(1):56. PubMed ID: 27371162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG
    Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.